Advances in Janus Kinase Inhibitors for Vitiligo Treatment
{{output}}
Vitiligo is a cutaneous autoimmune disease characterized by the destruction of epidermal melanocytes leading to white patches with a global prevalence of about 0.5-2%, and patients' quality of life are greatly affected by the change in appearance and social d... ...